4 Equity
Share capital
The share capital as of December 31, 2022, amounted to CHF 412’623.70, made up of 41’262’370 shares with dividend entitlement and a par value of CHF 0.01. All shares were fully paid in and registered.
As of December 31, 2022, the company had a remaining authorized share capital of CHF 10’000.00, corresponding to 1’000’000 shares at a nominal value of CHF 0.01 each. The Board of Directors is authorized to increase the share capital of the company by the aforementioned remaining amount, at any time, until September 20, 2023.
Share ownership
medmix shares are freely transferable provided that, when requested by the company to do so, buyers declare that they have purchased and will hold the shares in their own name and for their own account. Nominees will only be entered in the share register with the right to vote provided that they meet the following conditions: the nominee is subject to the supervision of a recognized banking and financial market regulator; the nominee has entered into an agreement with the Board of Directors concerning its status; the share capital held by the nominee does not exceed 3% of the registered share capital entered in the commercial register; and the names, addresses and number of shares of those individuals for whose accounts the nominee holds at least 0.5% of the share capital have been disclosed. The Board of Directors is also entitled, beyond these limits, to enter shares of nominees with voting rights in the share register, provided that the above-mentioned conditions are met (see also paragraph 6a of the Articles of Association at https://medmix.swiss/en/Investors/Governance).
Shareholders holding more than 3%
|
|
|
Dec 31, 2022 |
|
Dec 31, 2021 |
||||
|
|
|
Number of shares |
|
in % |
|
Number of shares |
|
in % |
|
Viktor Vekselberg (direct shareholder: Tiwel Holding AG) |
|
16’728’414 |
|
40.54 |
|
16’728’414 |
|
40.54 |
|
The Capital Group Companies, Inc. (direct shareholder: Capital Research and Management Company) |
|
2’065’631 |
|
5.01 |
|
2’065’631 |
|
5.01 |
|
FIL Limited |
|
2’025’719 |
|
4.90 |
|
2’025’719 |
|
4.90 |
|
UBS Fund Management (Switzerland) AG |
|
1’489’532 |
|
4.35 |
|
1’489’532 |
|
4.35 |
Legal capital reserves and free reserves
The share capital increase as of September 30, 2021, resulted in reserves from capital contribution of CHF 294’653k.
Treasury shares held by medmix Ltd
|
|
|
2022 |
|
2021 |
||||
|
thousands of CHF |
|
Number of shares |
|
Total transaction amount |
|
Number of shares |
|
Total transaction amount |
|
Balance as of January 1 / September 20 |
|
150’000 |
|
6’489 |
|
– |
|
– |
|
Purchase |
|
200’000 |
|
6’069 |
|
150’000 |
|
6’489 |
|
Share-based remuneration |
|
–2’464 |
|
–88 |
|
– |
|
– |
|
Balance as of December 31 |
|
347’536 |
|
12’470 |
|
150’000 |
|
6’489 |
The total number of treasury shares held by medmix Ltd as of December 31, 2022, amounted to 347'536 (December 31, 2021: 150’000), which are mainly held for the purpose of issuing shares under the management share-based payment programs.